[DOI] /j.issn
|
|
- Chad Johns
- 5 years ago
- Views:
Transcription
1 [ ]- - T- SPOT.TB T-SPOT.TB T-SPOT.TB86.5%(95%CI 71.2%~95.5%) 100%(95%CI 90.5%~100%) 52.9%(95%CI 27.8%~77.0%) 35.3%(95%CI 14.2%~61.7%) 80.0%(95%CI 64.4%~90.9%) 77.1%(95%CI 62.7%~88.0%) 64.3%(95%CI 35.1%~87.2%) 100%(95%CI 54.1%~100%)ROC T-SPOT.TB 47SFC/ % 88.2%- T-SPOT.TB T-SPOT.TB 47SFC/ [] - T-SPOT.TB [ ] R521.7 [ ] A [ ] (2018) [DOI] /j.issn tuberculous pleurisy ZHOU Min 1, YANG Qing-luan 2, CHEN Hua-xin 1, YU Zhi-ming 1, GAO Liang 1, LIU Qian-qian 2, OU Qin-fang 1* 1 Department of Pulmonary Diseases, Fifth People s Hospital of Wuxi, Wuxi, Jiangsu , China 2 Department of Infectious Diseases, Huashan Hospital affiliated to Fudan University, Shanghai , China * Corresponding author, @fudan.edu.cn This work was supported by the Project of Science and Technology of Wuxi (CSZ00N1229) [Abstract] Objective To evaluate the diagnostic value of interferon- release assay of blood and pleural effusion for tuberculous pleurisy. Methods Fifty-six adult patients with suspected tuberculous pleurisy were enrolled in our study. The blood and pleural effusion interferon- release assay were measured by T-SPOT.TB test in 38 pleural tuberculosis patients and 18 nontuberculous pleurisy controls. The diagnostic sensitivity, specificity, predictive value of T-SPOT.TB in pleural effusion mononuclear cells (PE-MC) and peripheral mononuclear cells (PBMC) were analyzed. Results The sensitivities and specificities, positive predictive values and negative predictive values, respectively, of the PE-MC and PBMC for diagnosing were as follows: 86.5%(95% confidence interval[ci] 71.2%-95.5%) and 100%(95%CI 90.5%-100%); 52.9%(95%CI 27.8%-77.0%) and 35.3%(95%CI 14.2%- 61.7%); 80.0%(95%CI 64.4%-90.9%) and 77.1%(95%CI 62.7%-88.0%); 64.3%(95%CI 35.1%-87.2%) and 100%(95%CI 54.1%- 100%). By ROC curve analysis, a cut-off value of 47SFC/ cells in PE-MC showed a sensitivity of 89.2% and a specificity of 88.2%. Conclusion T-SPOT.TB in PE-MC could be an accurate diagnostic method for tuberculous pleurisy in TB endemic settings. Moreover, 47SFC/ cells might be the optimal cut-off value for diagnosing tuberculous pleurisy. [Key words] interferon- release assay; T-SPOT.TB; pleural effusion; tuberculous pleurisy; diagnosis [ ] (CSZ00N1229) [ ] [ ] ( ) ( ) [ ] @fudan.edu.cn [1-2] [3-4] [5]
2 Med J Chin PLA, Vol. 43, No. 1, January 1, [6] [7] - (IFN- ) [8] T- SPOT.TB IFN- -6(early secretary antigenic target6 ESAT-6) -10(culture filtrate protein10 CFP-10) IFN- T [9] T-SPOT.TB ( ) () 1~3 < ml 50ml 1.2.2IFN- T-SPOT.TB(Oxford Immunotec Abingdon UK) (Mycobacterium tuberculosis)mtb 1(region of difference RD1) T 6h T-SPOT.TB ESAT-6(6 000kD) CFP-10(10 000kD) Ficoll-Hypaque (peripheral blood mononuclear cells PBMCs)(pleural effusion mononuclear cells PE-MCs) PBMCs PE-MCs - ( ) 37 5%CO 2 16~18h ELISPOT (spots forming cells SFC)6 2 PBMCs PE- MCs T-SPOT.TB 1.3SPSS 23.0 Mann-Whiney (Fisher's test) P< (30~72) (55~77) 15 (83.3%) 3 (16.7%) (P>0.05) (P=0.03) (P<0.01) ( 1) 2.2T-SPOT.TB T-SPOT.TB % 37 T- SPOT.TB 100% T- SPOT.TB % 17 T-SPOT.TB % T-SPOT.TB(P<0.05 1) T- SPOT.TB ESAT-6 CFP SFC/ T- SPOT.TB 86.5%(95%CI 71.2%~95.5%) 100%(95%CI 90.5%~100%) 52.9%(95%CI 27.8%~77.0%) 35.3%(95%CI 14.2%~61.7%) 80.0%(95%CI 64.4%~90.9%) 77.1%(95%CI 62.7%~88.0%) 64.3%(95%CI 35.1%~87.2%) 100%(95%CI
3 Tab.1 Comparison of various diagnostic index in 56 patients with suspected tuberculous pleurisy Item Tuberculous pleurisy (n=38) Non-tuberculous pleurisy (n=18) P value T-SPOT.TB [n(%)] PBMCs T-SPOT.TB 32/37(86.5) 8/17(47.1) PE-MCs T-SPOT.TB 37/37(100) 11/17(64.7) Blood [median (IQR)] WBC (10 9 /L) 5.57( ) 6.61( ) Neutrophil (%) 68.50( ) 71.25( ) Lymphocyte (%) 22.50( ) 19.00( ) Hb (g/l) ( ) ( ) PLT (10 9 /L) ( ) ( ) ESR (mm/h) 57.50( ) 38.00( ) CSF [median (IQR)] Protein (g/l) 40.95( ) 46.00( ) Lymphocyte (%) 84.00( ) 75.00( ) ADA (U/L) 42.60( ) 12.00( ) LDH (U/L) ( ) ( ) PBMCs. Peripheral blood mononuclear cells; PE-MCs. Pleural effusion mononuclear cells; WBC. White blood cell; Hb. Hemoglobin; PLT. Platelet; ESR. Erythrocyte sedimentation rate; ADA. Adenosine deaminase; LDH. Lactic dehydrogenase; IQR. Interquartile range IFN- producting T cell responses (SFC/ cells) IFN-ESAT-6 CFP-10 Fig.1 Box-and-whisker plot showing responses to ESAT-6 and CFP-10 according to the PBMC and PE-MC T-SPOY.TB PBMCs. Peripheral blood mononuclear cells; PE-MCs. Pleural effusion mononuclear cells; TB. Tuberculous pleurisy; non-tb. Nontuberculous pleurisy; A. ESAT-6; B. CFP-10; P<0.05 A B A B A B A B TB non-tb TB non-tb PBMCs PE-MCs 54.1%~100% 2) T- SPOT.TB 2.3 ROCT- SPOT.TB ROC 58 T- SPOT.TB T- SPOT.TB ROC (AUC) (95%CI 0.891~1.000 P<0.001) T-SPOT.TB AUC( %CI 0.666~0.860 P < )ROC T- SPOT.TB 47SFC/ % 88.2% 94.3% 78.9% T-SPOT.TB 97.4% 90.9% T-SPOT.TB (%) Tab.2 Diagnostic performance of PBMC and PE-MC T-SPOT.TB in the study population (%) T-SPOT.TB Sensitivity Specificity PPV NPV LR + LR PBMCs>6SFC ( ) 52.9( ) 80.0( ) 64.3( ) 1.84( ) 0.255( ) PE-MCs>6SFC 100.0( ) 35.3( ) 77.1( ) 100.0( ) 1.55( ) PE-MCs>47SFC ( ) 88.2( ) 94.3( ) 78.9( ) 7.58( ) 0.123( ) PBMCs>6SFC or PE-MCs>6SFC 100.0( ) 29.4( ) 75.5( ) 100.0( ) 1.42( ) PBMCs>6SFC or PE-MCs>47SFC 97.4( ) 55.6( ) 82.2( ) 90.9( ) 2.19( ) 0.047( ) PBMCs>6SFC and PE-MCs>6SFC 86.1( ) 56.3( ) 81.6( ) 64.3( ) 1.97( ) 0.247( ) PBMCs>6SFC and PE-MCs>47SFC 73.7( ) 88.9( ) 93.3( ) 61.5( ) 6.63( ) 0.296( ) PBMCs. Peripheral blood mononuclear cells; PE-MCs. Pleural effusion mononuclear cells; SFC. Spots forming cells; PPV. Positive predictive value; NPV. Negative predictive value; LR +. Positive likelihood ratio; LR. Negative likelihood ratio. 1 SFC is short for SFCs / mononuclear cells; 2 Cut-off derived from the area under the curve by the Youden index
4 Med J Chin PLA, Vol. 43, No. 1, January 1, Sensitivity specificity 2T-SPOT.TBROC Fig.2 ROC curves in PBMCs and PE-MCs T-SPOT.TB for diagnosis of tuberculous pleurisy ( 2) PBMC (0.7663) PE-MC (0.9459) T-SPOT.TB T-SPOT.TB T-SPOT.TB 6SFC/ IFN- MtbT T T Souza [10] T Barnes [11] CD4 + T T IFN- IFN- T-SPOT.TBT-SPOT.TB IFN- 93% [12] 6SFC/ T-SPOT.TB T-SPOT.TB 47SFC/ %89.2% 52.9%88.2% 80.0%94.3% 64.3%78.9% T- SPOT.TB 6SFC/ T- SPOT.TB [9] 187 T- SPOT.TB T- SPOT.TB 6SFC/ T-SPOT.TB ROC T- SPOT.TB AUC T- SPOT. TB(0.7663) T-SPOT.TB 47SFC/ T-SPOT.TB 89.2% 88.2% Zhang [13] 98 T-SPOT.TB (94.5%) (76.1%) 54 SFC/ T-SPOT.TB IFN- T-SPOT.TB T-SPOT.TB 47SFC/ T-SPOT.TB [1] Hooper CE, Lee YC, Maskell NA. Interferon-gamma release assays for the diagnosis of TB pleural effusions: hype or real hope?[ J]. Curr Opin Pulm Med, 2009, 15(4): [2] Shi XP, Wang J, Wang X, et al. Clinical application of T-spot test of Mycobacterium tuberculosis infection for diagnosis of suspected pulmonary tuberculosis patients[ J]. Med J Chin PLA, 2017, 42(11): [,,,. T [ J]., 2017, 42(11): ] [3] Porcel JM. Tuberculous pleural effusion[ J]. Lung, 2009, 187(5): [4] Liu HM, Chu Z, Tian R, et al. Application of IL-10 and IL-12 detection in differential diagnosis of tuberculous and malignant pleural effusion[ J]. J Jilin Univ (Med Ed), 2017, 43(4): , 861. [,,,. IL-10 IL-12 [ J]. ( ), 2017, 43(4): , 861.] [5] Greco S, Girardi E, Masciangelo R, et al. Adenosine deaminase and interferon gamma measurement for the diagnosis of tuberculous pleurisy: a meta-analysis[ J]. Int J Tuberc Lung Dis,
5 , 7(8): [6] Ou QF, Gao Y, Shao LY, et al. Assessment the diagnostic power by interferon-gamma release of the whole blood and pleural biopsy in tuberculous pleurisy[ J]. Chin J Exp Clin Infect Dis, 2014, 8(3): [,,,. [J]., 2014, 8(3): ] [7] Pai M, Zwerling A, Menzies D, et al. Systematic review: T-cellbased assays for the diagnosis of latent tuberculosis infection: an update[ J]. Ann Intern Med, 2008, 149(3): [8] Liu Y, Ou M, He S, et al. Evaluation of a domestic interferongamma release assay for detecting Mycobacterium tuberculosis infection in China[ J]. Tuberculosis (Edinb), 2015, 95(4): [9] Liu XQ. The clinical application of IGRA test in body fluid (serositis and cerebral spinal fluid) for diagnosis of tuberculosis[ J]. Chin J Antituberc, 2015, 37(7): [. -() [ J]., 2015, 37(7): ] [10] Souza MC, Penido C, Costa MF, et al. Mechanisms of T-lymphocyte accumulation during experimental pleural infection induced by Mycobacterium bovis BCG[ J]. Infect Immun, 2008, 76(12): [11] Barnes PF, Mistry SD, Cooper CL, et al. Compartmentalization of a CD4 + T lymphocyte subpopulation in tuberculous pleuritis[ J]. J Immunol, 1989, 142(4): [12] L i u Y, O u, Q, Z h e n g, J, et al. A combination of the QuantiFERON-TB gold in-tube assay and the detection of adenosine deaminase improves the diagnosis of tuberculous pleural effusion[ J]. Emerg Microbes Infect, 2016, 5(8): e83. [13] Zhang L, Zhang Y, Shi X, et al. Utility of T-cell interferon-gamma release assays for diagnosing tuberculous serositis: a prospective study in Beijing, China[ J]. PLoS One, 2014, 9: e ( ) ( )
Accuracy of enzyme-linked immunospot assay for diagnosis of pleural tuberculosis: a meta-analysis
Accuracy of enzyme-linked immunospot assay for diagnosis of pleural tuberculosis: a meta-analysis Z.Z. Li 1, W.Z. Qin 1, L. Li 1, Q. Wu 1 and Y.J. Wang 1,2 1 West China School of Medicine/West China Hospital,
More informationResearch Article Interferon-Gamma Release Assay Performance of Cerebrospinal Fluid and Peripheral Blood in Tuberculous Meningitis in China
Hindawi BioMed Research International Volume 2017, Article ID 8198505, 10 pages https://doi.org/10.1155/2017/8198505 Research Article Interferon-Gamma Release Assay Performance of Cerebrospinal Fluid and
More informationDiagnostic Value of ELISPOT Technique for Osteoarticular Tuberculosis
Clin. Lab. 2014;60:1865-1870 Copyright ORIGINAL ARTICLE Diagnostic Value of ELISPOT Technique for Osteoarticular Tuberculosis XUEQIONG WU 1, *, YUANZHENG MA 2, *, LAN WANG 1, DAWEI LI 2, YOURONG YANG 1,
More informationDiagnostic accuracy of T-cell interferon-gamma release assays in. tuberculous pleurisy: a meta-analysis *
Diagnostic accuracy of T-cell interferon-gamma release assays in tuberculous pleurisy: a meta-analysis * Qiong Zhou, 1 * Yi-Qiang Chen, 2 * Shou-Ming Qin, 2 Xiao-Nan Tao, 1 Jian-Bao Xin 1 and Huan-Zhong
More informationEffect of prolonged incubation time on the results of the QuantiFERON TB Gold In-Tube assay for the diagnosis of latent tuberculosis infection
CVI Accepts, published online ahead of print on 3 July 2013 Clin. Vaccine Immunol. doi:10.1128/cvi.00290-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 3 Effect of prolonged
More informationTB Prevention Who and How to Screen
TB Prevention Who and How to Screen 4.8.07. IUATLD 1st Asia Pacific Region Conference 2007 Dr Cynthia Chee Dept of Respiratory Medicine / TB Control Unit Tan Tock Seng Hospital, Singapore Cycle of Infection
More informationKinetics of T-cell-based assays on cerebrospinal fluid and peripheral blood mononuclear cells in patients with tuberculous meningitis
ORIGINAL ARTICLE Korean J Intern Med 214;29:793-799 http://dx.doi.org/1.394/kjim.214.29.6.793 Kinetics of T-cell-based assays on cerebrospinal fluid and peripheral blood mononuclear cells in patients with
More informationThe immunologic paradox in the diagnosis of
CVI Accepts, published online ahead of print on 21 October 2009 Clin. Vaccine Immunol. doi:10.1128/cvi.00321-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationAPPLICATION OF IMMUNO CHROMATOGRAPHIC METHODS IN PLEURAL TUBERCULOSIS
APPLICATION OF IMMUNO CHROMATOGRAPHIC METHODS IN PLEURAL TUBERCULOSIS Hadizadeh Tasbiti.AR, Yari.SH, Bahrmand.AR, Karimi.A,Fateh.A, Sayfi.M Tuberculosis Dept.Pasteur Institute of Iran.Tehran.Iran 1 INTRODUCTION
More informationTuberculosis and cancer
Tuberculosis and cancer David P. Holland, MD, MHS Chief Clinical Officer, CDPB Fulton County Department of Health and Wellness Assistant Professor, Emory University Disclosures No relevant financial disclosures
More informationAndrew Ramsay Secretary STP Working Group on New Diagnostics WHO/TDR 20, Avenue Appia CH-1211, Geneva 27, Switzerland
Stop TB Partnership 20, Avenue Appia CH-1211 Geneva 27 Switzerland Tel. (41) 22 791 2708 Fax. (41) 22 791 4886 Visit us on our website www.stoptb.org Direct: (41) 22 791 1545 E-mail: ramsaya@who.int In
More informationMore significance of TB- IGRA except for the diagnose of tuberculosis
Received: 16 August 2016 Accepted: 20 January 2017 DOI: 10.1002/jcla.22183 RESEARCH ARTICLE More significance of TB- IGRA except for the diagnose of tuberculosis Jun-Chi Xu 1,2 Ze-Yi Li 1 Xin-Nian Chen
More informationUniversity of Groningen
University of Groningen Positive predictive value of ELISpot in BAL and pleural fluid from patients with suspected pulmonary tuberculosis Hofland, Regina W.; Thijsen, Steven F. T.; van Lindert, Anne S.
More informationDiagnostic accuracy of interferon-gamma in pericardial effusions for tuberculous pericarditis: a meta-analysis
Original Article Diagnostic accuracy of interferon-gamma in pericardial effusions for tuberculous pericarditis: a meta-analysis Chao Liu 1 *, Yun-Liang Cui 2 *, Chun-Mei Ding 3, Yan-Hua Wu 3, Hui-Li Li
More informationTB Intensive Houston, Texas October 15-17, 2013
TB Intensive Houston, Texas October 15-17, 2013 Interferon Gamma Release Assays (IGRA s) Lisa Armitige, MD, PhD October 16, 2013 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict
More informationDiagnosis of Central Nervous System Tuberculosis by T-Cell-Based Assays on Peripheral Blood and Cerebrospinal Fluid Mononuclear Cells
CLINICAL AND VACCINE IMMUNOLOGY, Sept. 2008, p. 1356 1362 Vol. 15, No. 9 1556-6811/08/$08.00 0 doi:10.1128/cvi.00040-08 Copyright 2008, American Society for Microbiology. All Rights Reserved. Diagnosis
More informationTB Intensive San Antonio, Texas November 11 14, 2014
TB Intensive San Antonio, Texas November 11 14, 2014 Interferon Gamma Release Assays Lisa Armitige, MD, PhD November 12, 2014 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of
More informationTB Intensive Tyler, Texas December 2-4, 2008
TB Intensive Tyler, Texas December 2-4, 2008 Interferon Gamma Releasing Assays: Diagnosing TB in the 21 st Century Peter Barnes, MD December 2, 2008 TOPICS Use of interferon-gamma release assays (IGRAs)
More informationEvaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014
Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014 Interferon Gamma Release Assays: Understanding the Test David Griffith, BA, MD April 11, 2014 David Griffith, BA, MD has the following
More informationVariation in T-SPOT.TB spot interpretation between independent observers of different laboratories
8 Variation in T-SPOT.TB spot interpretation between independent observers of different laboratories Willeke P.J. Franken 1, Steven Thijsen 2, Ron Wolterbeek 3, John J.M. Bouwman 2, Hanane el Bannoudi
More informationTitle: Role of Interferon-gamma Release Assays in the Diagnosis of Pulmonary Tuberculosis in Patients with Advanced HIV infection
Author's response to reviews Title: Role of Interferon-gamma Release Assays in the Diagnosis of Pulmonary Tuberculosis in Patients with Advanced HIV infection Authors: Adithya Cattamanchi (acattamanchi@medsfgh.ucsf.edu)
More informationPreface. Date: May 1, 2003 Vol.1/MX-2/05/03
Date: May 1, 2003 Vol.1/MX-2/05/03 Preface Tulip Group of companies believes in offering our valued customers the technical support and scientific information to keep updated with the latest international
More informationApproaches to LTBI Diagnosis
Approaches to LTBI Diagnosis Focus on LTBI October 8 th, 2018 Michelle Haas, M.D. Associate Director Denver Metro Tuberculosis Program Denver Public Health DISCLOSURES I have no disclosures or conflicts
More informationUsefulness of interferon-γ release assay for the diagnosis of sputum smear-negative pulmonary and extra-pulmonary TB in Zhejiang Province, China
Ji et al. Infectious Diseases of Poverty (2017) 6:121 DOI 10.1186/s40249-017-0331-1 RESEARCH ARTICLE Open Access Usefulness of interferon-γ release assay for the diagnosis of sputum smear-negative pulmonary
More informationDIAGNOSTIC UTILITY OF PLEURAL FLUID AND SERUM MARKERS IN DIFFERENTIATION BETWEEN MALIGNANT AND NON-MALIGNANT PLEURAL EFFUSIONS
128 EUROPEAN JOURNAL OF MEDICAL RESEARCH December 7, 2009 Eur J Med Res (2009) 14(Suppl. IV): 128-133 I. Holzapfel Publishers 2009 DIAGNOSTIC UTILITY OF PLEURAL FLUID AND SERUM MARKERS IN DIFFERENTIATION
More informationWhat the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis
What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Microbiology Epidemiology Common disease presentations Diagnosis of active
More informationQualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment
ORIGINAL ARTICLE Korean J Intern Med 217;32:32-38 https://doi.org/1.394/kjim.216.199 Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis
More informationAtypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions
ORIGINAL ARTICLE Atypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions Chang Ho Kim, So Yeon Lee, Yong Dae Lee,
More informationT-CELL RESPONSES ASSESSED USING IGRA AND TST ARE NOT CORRELATED WITH AFB GRADE AND CHEST RADIOGRAPH IN PULMONARY TUBERCULOSIS PATIENTS
T-CELL RESPONSES ASSESSED USING IGRA AND TST ARE NOT CORRELATED WITH AFB GRADE AND CHEST RADIOGRAPH IN PULMONARY TUBERCULOSIS PATIENTS Kiatichai Faksri 1, 4, Wipa Reechaipichitkul 2, 4, Wilailuk Pimrin
More informationLet s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year
A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Madhukar Pai, MD, PhD Author and Series Editor Camilla Rodrigues, MD co-author Abstract Most individuals who get exposed
More informationTB Nurse Case Management San Antonio, Texas July 18 20, 2012
TB Nurse Case Management San Antonio, Texas July 18 20, 2012 IGRA s and Their Use in TB Nurse NCM Lisa Armitige, MD, PhD July 18, 2012 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict
More informationThe World Health Organization s strategy. Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts
Eur Respir J 21; 36: 594 6 DOI: 1.1183/931936.17159 CopyrightßERS 21 Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts T. Oni*,#, J. Patel ", H.P. Gideon*, R. Seldon*,
More informationMAIT cell function is modulated by PD-1 signaling in patients with active
MAIT cell function is modulated by PD-1 signaling in patients with active tuberculosis Jing Jiang, M.D., Xinjing Wang, M.D., Hongjuan An, M.Sc., Bingfen Yang, Ph.D., Zhihong Cao, M.Sc., Yanhua Liu, Ph.D.,
More informationTuberculosis (TB) is an important global health problem. A
Monitoring of Peptide-Specific and Gamma Interferon-Productive T Cells in Patients with Active and Convalescent Tuberculosis Using an Enzyme-Linked Immunosorbent Spot Assay Fang-Fang Yang, a Zhi-Quan Tu,
More informationSilicotic subjects are at a high risk of. Comparison of T-Spot.TB and tuberculin skin test among silicotic patients
Eur Respir J 2008; 31: 266 272 DOI: 10.1183/09031936.00054707 CopyrightßERS Journals Ltd 2008 Comparison of T-Spot.TB and tuberculin skin test among silicotic patients C.C. Leung*, W.C. Yam #, W.W. Yew
More information23.45 (95%CI ) 0.11 (95%CI ) (95%CI ) (pleural effusion);
CHEST -γ -γ -γ -γ 22 -γ 0.89 (95%CI 0.87 0.91) 0.97 (95%CI 0.96 0.98) 23.45 (95%CI 17.31 31.78) 0.11 (95%CI 0.07 0.16) 272.7 (95%CI 147.5 504.2) -γ -γ -γ (interferon); (pleural effusion); (tuberculosis)
More informationWhat the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB
What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Common disease presentations Diagnosis of active TB Screening
More informationTargeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University Tuberculosis Estimates USA World Infection 15,000,000 2,000,000,000
More informationThe Value of T-SPOT.TB Technology in the Diagnosis of Tuberculosis in Elderly Patients B Sun 1, L Ma 1, J Wu 1, H Kuang 1, L Zhao 1 ABSTRACT
The Value of T-SPOT.TB Technology in the Diagnosis of Tuberculosis in Elderly Patients B Sun 1, L Ma 1, J Wu 1, H Kuang 1, L Zhao 1 ABSTRACT Objectives: To investigate the clinical value of T-SPOT.TB technology
More informationThe role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China
Journal of Crohn's and Colitis (2012) 6, 317 323 Available online at www.sciencedirect.com The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease
More informationUse of Interferon-γ Release Assays (IGRAs) in TB control in low and middle-income settings - EXPERT GROUP MEETING -
Use of Interferon-γ Release Assays (IGRAs) in TB control in low and middle-income settings - EXPERT GROUP MEETING - Date and time: 20-21 July 2010, 09:00 18:00 Venue: Salle B, WHO-HQ, Geneva, Switzerland
More informationThe importance of the biomarkers, ADA, CRP and INF-γ, in diagnosing pleural effusion etiologies
The importance of the biomarkers, ADA, CRP and INF-γ, in diagnosing pleural effusion etiologies (The importance of the biomarkers ADA, CRP and INF-γ in facilitating the diagniosis of pleural effusion etiologies,
More informationDetecting latent tuberculosis using interferon gamma release assays (IGRA)
Detecting latent tuberculosis using interferon gamma release assays (IGRA) American Society for Microbiology June 2017 Edward Desmond, Ph.D., D (ABMM) San Lorenzo, CA Edward Desmond has no financial connections
More informationIMMUNOLOGY & MEDICAL MICROBIOLOGY
RESEARCH ARTICLE Interferon gamma release assay in diagnosis of pediatric tuberculosis: a meta-analysis Lin Sun, Jing Xiao, Qing Miao, Wei-xing Feng, Xi-rong Wu, Qing-qin Yin, Wei-wei Jiao, Chen Shen,
More informationPeggy Leslie-Smith, RN
Peggy Leslie-Smith, RN EMPLOYEE HEALTH DIRECTOR - AVERA TRAINING CONTENT 1. South Dakota Regulations 2. Iowa Regulations 3. Minnesota Regulations 4. Interferon Gamma Release Assay (IGRA)Testing 1 SOUTH
More informationResearch Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012
Research Methods for TB Diagnostics Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012 Overview Why do we need good TB diagnostics? What works? What doesn t work? How
More informationDifferent characteristics of tuberculous pleural effusion according to pleural fluid cellular predominance and loculation
Original Article Different characteristics of tuberculous pleural effusion according to pleural fluid cellular predominance and loculation Jaehee Lee 1, Jae Kwang Lim 2, Seung Soo Yoo 1, Shin Yup Lee 1,
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Portevin D, Moukambi F, Clowes P, et
More informationApplication Values of T-SPOT.TB in Clinical Rapid Diagnosis of Tuberculosis
Iran J Public Health, Vol. 47, No.1, Jan 2018, pp.18-23 Original Article Application Values of T-SPOT.TB in Clinical Rapid Diagnosis of Tuberculosis Feng ZHU, Qinfang OU, *Jian ZHENG Dept. of Pulmonology,
More informationRecruitment of Mycobacterium tuberculosis specific CD4 + T cells to the site of infection for diagnosis of active tuberculosis
Original Article doi: 10.1111/j.1365-2796.2008.02012.x Recruitment of Mycobacterium tuberculosis specific CD4 + T cells to the site of infection for diagnosis of active tuberculosis J. Nemeth 1,2, H.-M.
More informationBarbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast
Practical Aspects for Using the Interferon Gamma Release Assay (IGRA) Test Live Webinar July 14, 2017 Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and
More informationTHE SENSITIVITY AND SPECIFICITY OF PLEURAL FLUID MTB-SPECIFIC ELISPOT ASSAY AMONG ADULTS WITH SUSPECTED TUBERCULOUS PLEURISY
THE SENSITIVITY AND SPECIFICITY OF PLEURAL FLUID MTB-SPECIFIC ELISPOT ASSAY AMONG ADULTS WITH SUSPECTED TUBERCULOUS PLEURISY COMPARED TO PLEURAL BIOPSY IN MULAGO HOSPITAL REJANI LALITHA (MBChB, MAK) 2009
More informationInterpretation of TST & IGRA results. Objectives
Interpretation of TST & IGRA results Randall Reves, MD, MSc Volunteer Clinician Denver Metro TB Program and Division of Infectious Diseases, Department of Medicine University of Colorado Denver Objectives
More informationIdentifying TB co-infection : new approaches?
Identifying TB co-infection : new approaches? Charoen Chuchottaworn MD. Senior Medical Advisor, Central Chest Institute of Thailand, Department of Medical Services, MoPH Primary tuberculosis Natural history
More informationDiagnosis Latent Tuberculosis. Disclosures. Case
Diagnosis Latent Tuberculosis Neha Shah MD MPH Field Medical Officer Tuberculosis Control Branch California Department of Public Health Centers for Disease Control and Prevention September 2016 1 Disclosures
More informationOriginal Article Evaluation of Xpert MTB/RIF in detection of pulmonary and extrapulmonary tuberculosis cases in China
Int J Clin Exp Pathol 2017;10(4):4847-4851 www.ijcep.com /ISSN:1936-2625/IJCEP0045802 Original Article Evaluation of Xpert MTB/RIF in detection of pulmonary and extrapulmonary tuberculosis cases in China
More informationUse of an Interferon- Release Assay To Diagnose Latent Tuberculosis Infection in Foreign-Born Patients*
Original Research MYCOBACTERIAL DISEASE Use of an Interferon- Release Assay To Diagnose Latent Tuberculosis Infection in Foreign-Born Patients* Daniel Brodie, MD; David J. Lederer, MD, MS; Jade S. Gallardo,
More informationCombined efficacy of pleural fluid lymphocyte neutrophil ratio and pleural fluid adenosine deaminase for the diagnosis of tubercular pleural effusion
Original article: Combined efficacy of pleural fluid lymphocyte neutrophil ratio and pleural fluid adenosine deaminase for the diagnosis of tubercular pleural effusion Kavita S Kore, Guruprasad Antin,
More informationTunn Ren Tay * and Augustine Tee
Tay and Tee BMC Infectious Diseases 2013, 13:546 RESEARCH ARTICLE Open Access Factors affecting pleural fluid adenosine deaminase level and the implication on the diagnosis of tuberculous pleural effusion:
More informationTesting for TB. Bart Van Berckelaer Territory Manager Benelux. Subtitle
Testing for TB Bart Van Berckelaer Territory Manager Benelux Subtitle Agenda TB infection pathway TB immunisation Testing options Pre lab considerations of the whole blood ELISA test The T-SPOT.TB test
More informationDiagnostic Usefulness of a T-cell-based Assay for Extrapulmonary Tuberculosis in Immunocompromised Patients
CLINICAL RESEARCH STUDY Diagnostic Usefulness of a T-cell-based Assay for Extrapulmonary Tuberculosis in Immunocompromised Patients Sung-Han Kim, MD, a,b,c Kyoung-Ho Song, MD, a Su-Jin Choi, MS, b Hong-Bin
More informationUsing Interferon Gamma Release Assays for Diagnosis of TB Infection
Learning Objectives Using Interferon Gamma Release Assays for Diagnosis of TB Infection 1. Describe available Interferon Gamma Release Assay tests for TB infection and how they work. 2. Understand interpretation
More informationMaking the Diagnosis of Tuberculosis
Making the Diagnosis of Tuberculosis Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Testing for TB Infection Targeted Testing: Key Points Test only if plan for ensuring treatment De-emphasizes
More informationTuberculosis (TB) remains a major cause of. Use of a T-cell interferon-c release assay for the diagnosis of tuberculous pleurisy
Eur Respir J 2007; 30: 1173 1179 DOI: 10.1183/09031936.00067307 CopyrightßERS Journals Ltd 2007 Use of a T-cell interferon-c release assay for the diagnosis of tuberculous pleurisy M. Losi*, A. Bossink
More informationWithin-Subject Variability of Mycobacterium tuberculosis-specific Gamma Interferon Responses in German Health Care Workers
CLINICAL AND VACCINE IMMUNOLOGY, July 2011, p. 1176 1182 Vol. 18, No. 7 1556-6811/11/$12.00 doi:10.1128/cvi.05058-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Within-Subject
More informationTuberculin Skin Test (TST) and Interferon-gamma Release Assays (IGRA)
Tuberculin Skin Test (TST) and Interferon-gamma Release Assays (IGRA) April 2019 Bob Belknap M.D. Director, Denver Metro TB Program Disclosures No relevant financial relationships Objectives Be able to
More informationReview. Interferon- assays in the immunodiagnosis of tuberculosis: a systematic review. Interferon- assays for tuberculosis diagnosis
Interferon- assays for tuberculosis diagnosis Review Interferon- assays in the immunodiagnosis of tuberculosis: a systematic review Madhukar Pai, Lee W Riley, and John M Colford Jr A major challenge in
More informationJMSCR Vol 05 Issue 05 Page May 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i5.52 Utility of serum ADA estimation in the
More informationTo study the combined use of pleural fluid lymphocyte/ neutrophil ratio and ADA for the diagnosis of tuberculous pleural effusion
and ADA for the diagnosis of tuberculous. IAIM, 2017; 4(9): 1-5. Original Research Article To study the combined use of fluid lymphocyte/ neutrophil ratio and ADA for the diagnosis of tuberculous Ramasamy
More informationRichard N. van Zyl-Smit 1, Rannakoe J. Lehloenya 1,2, Richard Meldau 1, Keertan Dheda 1,3,4. Introduction
Original Article Impact of correcting the lymphocyte count to improve the sensitivity of TB antigen-specific peripheral blood-based quantitative T cell assays (T-SPOT. TB and QFT-GIT) Richard N. van Zyl-Smit
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
TB Partial Update Appendix 1 - Scope NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis (partial
More informationCritical Evaluation of Tuberculosis Diagnostic Tests in Low- and High- Burden Settings
Critical Evaluation of Tuberculosis Diagnostic Tests in Low- and High- Burden Settings by John Metcalfe Dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy
More informationAnalysis of an Interferon-Gamma Release Assay for Monitoring the Efficacy of Anti-Tuberculosis Chemotherapy
Jpn. J. Infect. Dis., 64, 133-138, 2011 Original Article Analysis of an Interferon-Gamma Release Assay for Monitoring the Efficacy of Anti-Tuberculosis Chemotherapy Kiyoko Takayanagi, Misako Aoki, Kumiko
More informationMycobacterial Infections: What the Primary Provider Should Know about Tuberculosis
Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening
More informationDiagnosis of Active Tuberculosis in China Using an In-House Gamma Interferon Enzyme-Linked Immunospot Assay
CLINICAL AND VACCINE IMMUNOLOGY, June 2009, p. 879 884 Vol. 16, No. 6 1556-6811/09/$08.00 0 doi:10.1128/cvi.00044-09 Copyright 2009, American Society for Microbiology. All Rights Reserved. Diagnosis of
More informationFactors Associated with Indeterminate and False Negative Results of QuantiFERON-TB Gold In-Tube Test in Active Tuberculosis
http://dx.doi.org/10.4046/trd.2012.72.5.416 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2012;72:416-425 CopyrightC2012. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights
More informationLaboratory Updates on IGRA Testing
Laboratory Updates on IGRA Testing Edward A. Graviss, PhD, MPH, FIDSA August 18, 2017 EXCELLENCE EXPERTISE INNOVATION Edward A. Graviss, PhD, MPH, FIDSA, has the following disclosures to make: No conflict
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis (partial update) 1.1 Short title Tuberculosis
More informationDiagnosis of tuberculosis: principles and practice of using interferon- release assays (IGRAs)
Diagnosis of tuberculosis: principles and practice of using interferon- release assays (IGRAs) Educational aims To provide an overview of interferon- release assays (IGRAs) used for detection of tuberculosis
More informationXiao-Ling Chi, Mei-Jie Shi, Huan-Ming Xiao, Yu-Bao Xie, and Gao-Shu Cai. Correspondence should be addressed to Xiao-Ling Chi;
Evidence-Based Complementary and Alternative Medicine Volume 2016, Article ID 3743427, 6 pages http://dx.doi.org/10.1155/2016/3743427 Research Article The Score Model Containing Chinese Medicine Syndrome
More informationPost-treatment change in Mycobacterium tuberculosis antigenstimulated tumor necrosis factor-alpha release in patients with active tuberculosis
Brief Report Post-treatment change in Mycobacterium tuberculosis antigenstimulated tumor necrosis factor-alpha release in patients with active tuberculosis Chang Ho Kim, Seung Soo Yoo, Shin Yup Lee, Seung
More informationThe Challenges and Pitfalls in Diagnosing or Misdiagnosing Tuberculosis: Are the Days of TB Skin Tests Over?
The Challenges and Pitfalls in Diagnosing or Misdiagnosing Tuberculosis: Are the Days of TB Skin Tests Over? ROY F. CHEMALY, MD, MPH, FIDSA, FACP PROFESSOR OF MEDICINE DIRECTOR, INFECTION CONTROL SECTION
More informationSupplemental Figure 1. Gating strategies for flow cytometry and intracellular cytokinestaining
Supplemental Figure 1. Gating strategies for flow cytometry and intracellular cytokinestaining of PBMCs. Forward scatter area (FSC-A) versus side scatter area (SSC-A) was used to select lymphocytes followed
More informationZahedan Journal of Research in Medical Sciences. Journal homepage:
Zahedan Journal of Research in Medical Sciences Journal homepage: www.zjrms.ir Diagnostic Accuracy of Pleural Fluid Soluble Interleukin 2 Receptor in Patients with Tuberculous Pleural Effusion Kourosh
More informationInterferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines
Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines Historically, Latent Tuberculosis Infection (LTBI) diagnosis was based on risk assessment, chest x-ray (CXR)
More informationTuberculosis (TB) remains a major global. Are interferon-c release assays useful for diagnosing active tuberculosis in a high-burden setting?
Eur Respir J 2011; 38: 649 656 DOI: 10.1183/09031936.00181610 CopyrightßERS 2011 Are interferon-c release assays useful for diagnosing active tuberculosis in a high-burden setting? D.I. Ling*, M. Pai*,
More informationPredictive values of IGRAs and TST for progression to active disease in TB. 3 rd Global IGRA Symposium January 2012.
Predictive values of IGRAs and for progression to active disease in TB contacts in Singapore Cynthia B E Chee 1, K W KhinMar 1, S H Gan 1, J Cutter, T M Barkham, Y T Wang 1 1 TB Control Unit, Tan Tock
More informationJournal of Infectious Diseases Advance Access published August 2, 2013
Journal of Infectious Diseases Advance Access published August 2, 2013 1 Reversion and Conversion of Interferon-gamma Release Assay Results in HIV-1 Infected Individuals Maximilian C. Aichelburg 1,*, Thomas
More informationInternational Journal of Innovative Research in Medical Science (IJIRMS)
Open Access Journal Research Article DOI: 10.23958/ijirms/vol02-i11/13 Efficacy of IGRA in the Diagnosis of Tuberculosis and its Correlation with Fluorescence Microscopy and Chest X-Ray in a Tertiary Care
More informationORIGINAL ARTICLE. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
ERJ Express. Published on July 25, 2007 as doi: 10.1183/09031936.00040007 ORIGINAL ARTICLE Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Yoshihiro Kobashi, Keiji Mouri, Yasushi
More informationInterferon-gamma release assay for treatment monitoring of active tuberculosis
JCM Accepts, published online ahead of print on 21 November 2012 J. Clin. Microbiol. doi:10.1128/jcm.02278-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Interferon-gamma
More informationEvidence-based use of the new diagnostic tools for TB-infection
Evidence-based use of the new diagnostic tools for TB-infection Roland Diel, MD, MPH German Central Committee against Tuberculosis, Germany 20. Tuberkulose-Symposium in Münchenwiler, 24 th March 2011 1
More informationPreclinical study and phase I clinical safety evaluation of recombinant Mycobacterium tuberculosis ESAT6 protein
eissn 2325-4416 DOI: 10.12659/MSMBR.883912 Received: 2012.10.19 Accepted: 2013.03.04 Published: 2013.05.15 Preclinical study and phase I clinical safety evaluation of recombinant Mycobacterium tuberculosis
More informationDiagnostic accuracy of tumor markers for malignant pleural effusion: a derivation and validation study
Original Article Diagnostic accuracy of tumor markers for malignant pleural effusion: a derivation and validation study Kan Zhai 1,2, Wen Wang 1, Yao Wang 1, Jing-Yuan Liu 3, Qiong Zhou 3, Huan-Zhong Shi
More informationTechnical Bulletin No. 172
CPAL Central Pennsylvania Alliance Laboratory QuantiFERON -TB Gold Plus Assay Contact: J Matthew Groeller, MPA(HCM), MT(ASCP), 717-851-4516 Operations Manager, Clinical Pathology, CPAL Jennifer Thebo,
More informationEvaluation of Mycobacterium tuberculosis specific T cell response to ESAT-6 and PPD antigen with ELISPOT assay
In the name of God Evaluation of Mycobacterium tuberculosis specific T cell response to ESAT-6 and PPD antigen with ELISPOT assay presented by: M. Taheri Symptoms of TB Cough for more than two week Bloody
More informationDimitrios Vassilopoulos,* Stamatoula Tsikrika, Chrisoula Hatzara, Varvara Podia, Anna Kandili, Nikolaos Stamoulis, and Emilia Hadziyannis
CLINICAL AND VACCINE IMMUNOLOGY, Dec. 2011, p. 2102 2108 Vol. 18, No. 12 1556-6811/11/$12.00 doi:10.1128/cvi.05299-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Comparison
More informationORIGINAL ARTICLE /j x. and 3 Department of Internal Medicine, University of Tor Vergata, Rome, Italy
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01391.x Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study D. Goletti 1,2, S. Carrara
More informationTitle: Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study
Author's response to reviews Title: Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study Authors: Delia Goletti (d.goletti@tiscali.it)
More information